These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16620021)

  • 1. The role of probiotics and antibiotics in regulating mucosal inflammation.
    Duchmann R
    Adv Exp Med Biol; 2006; 579():219-26. PubMed ID: 16620021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
    Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
    Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal bacteria and inflammatory bowel disease.
    Macfarlane S; Steed H; Macfarlane GT
    Crit Rev Clin Lab Sci; 2009; 46(1):25-54. PubMed ID: 19107650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the role of the enteric commensal flora in IBD?
    Guarner F
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S83-4. PubMed ID: 18816773
    [No Abstract]   [Full Text] [Related]  

  • 5. Probiotics and inflammatory bowel diseases.
    Bai AP; Ouyang Q
    Postgrad Med J; 2006 Jun; 82(968):376-82. PubMed ID: 16754706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.
    Andoh A; Fujiyama Y
    World J Gastroenterol; 2006 Jul; 12(28):4452-60. PubMed ID: 16874854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics in inflammatory bowel disease--therapeutic rationale and role.
    Shanahan F
    Adv Drug Deliv Rev; 2004 Apr; 56(6):809-18. PubMed ID: 15063591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbes, intestinal inflammation and probiotics.
    Khan MW; Kale AA; Bere P; Vajjala S; Gounaris E; Pakanati KC
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):81-94. PubMed ID: 22149584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of microecology in chronic inflammatory bowel diseases.
    Guarner F; Casellas F; Borruel N; Antolín M; Videla S; Vilaseca J; Malagelada JR
    Eur J Clin Nutr; 2002 Dec; 56 Suppl 4():S34-8. PubMed ID: 12556945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bacteria in experimental colitis.
    Guarner F; Malagelada JR
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):793-804. PubMed ID: 14507589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract.
    Daniluk U; Alifier M; Kaczmarski M
    Adv Med Sci; 2012; 57(2):175-82. PubMed ID: 22968339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
    Vanderpool C; Yan F; Polk DB
    Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action of probiotics: recent advances.
    Ng SC; Hart AL; Kamm MA; Stagg AJ; Knight SC
    Inflamm Bowel Dis; 2009 Feb; 15(2):300-10. PubMed ID: 18626975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microecology as a target for therapeutic intervention in inflammatory bowel disease.
    Guarner F
    IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and inflammatory bowel disease.
    Hammer HF
    Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip.
    Kim HJ; Li H; Collins JJ; Ingber DE
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E7-15. PubMed ID: 26668389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Lactic Acid Probiotic Bacteria in IBD.
    Vemuri R; Gundamaraju R; Eri R
    Curr Pharm Des; 2017; 23(16):2352-2355. PubMed ID: 28176664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evidence for immunomodulatory effects of probiotic bacteria.
    Ruemmele FM; Bier D; Marteau P; Rechkemmer G; Bourdet-Sicard R; Walker WA; Goulet O
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):126-41. PubMed ID: 19179874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioecological control of inflammatory bowel disease.
    Bengmark S
    Clin Nutr; 2007 Apr; 26(2):169-81. PubMed ID: 17113199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease.
    Sun J; Shen X; Li Y; Guo Z; Zhu W; Zuo L; Zhao J; Gu L; Gong J; Li J
    Nutrients; 2016 Jan; 8(1):. PubMed ID: 26784223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.